Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients-Reference-Cited by-同舟云学术

Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients

Published:2018-04 Issue:4 Volume:68 Page:764-772
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lee Yong-ho,Kim Kwang Joon,Yoo Myung eun,Kim Gyuri,Yoon Hye-jin,Jo Kwanhyeong,Youn Jong-Chan,Yun Mijin,Park Jun Yong,Shim Chi Young,Lee Byung-Wan,Kang Seok-Min,Ha Jong-Won,Cha Bong-Soo,Kang Eun Seok

Funder

Faculty Research Assistance Program of Yonsei University College of Medicine

National Research Foundation of Korea

Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea

Publisher

Elsevier BV

Subject

Hepatology

Reference68 articles.

1. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

2. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

3. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012

4. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

5. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008–2011);Lee;Hepatology,2016

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease;Nutrition, Metabolism and Cardiovascular Diseases;2024-09

2. Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies;Lipids in Health and Disease;2024-08-31

3. Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases;Frontiers in Cell and Developmental Biology;2024-07-16

4. Hepatocardial relationships in non-alcoholic fatty liver disease: issues of epidemiology, diagnosis, prognosis;Kazan medical journal;2024-06-26

5. Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis;European Radiology;2024-05-25